ADAP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Adaptimmune Therapeutics Plc (ADAP).


$137.87M Market Cap.

As of 03/24/2025 5:00 PM ET (MRY) • Disclaimer

ADAP Market Cap. (MRY)


ADAP Shares Outstanding (MRY)


ADAP Assets (MRY)


Total Assets

$245.96M

Total Liabilities

$234.11M

Total Investments

$60.47M

ADAP Income (MRY)


Revenue

$178.03M

Net Income

-$70.81M

Operating Expense

$246.72M

ADAP Cash Flow (MRY)


CF Operations

-$73.21M

CF Investing

-$58.95M

CF Financing

$78.75M

ADAP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ADAP Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$245,963,000 (-12.97%)

$282,616,000 (-14.08%)

$328,916,000 (-29.95%)

$469,545,000 (4.08%)

Assets Current

$188,169,000 (-9.34%)

$207,552,000 (-18.72%)

$255,370,000 (-38.53%)

$415,458,000 (4.35%)

Assets Non-Current

$57,794,000 (-23.01%)

$75,064,000 (2.06%)

$73,546,000 (35.98%)

$54,087,000 (2.07%)

Goodwill & Intangible Assets

$3,880,000 (1075.76%)

$330,000 (-25.34%)

$442,000 (-55.80%)

$1,000,000 (-42.20%)

Shareholders Equity

$11,849,000 (-70.01%)

$39,513,000 (-51.74%)

$81,878,000 (-60.25%)

$205,960,000 (-39.64%)

Property Plant & Equipment Net

$51,218,000 (-28.57%)

$71,708,000 (0.24%)

$71,535,000 (39.26%)

$51,369,000 (10.10%)

Cash & Equivalents

$93,206,000 (-36.60%)

$147,017,000 (34.14%)

$109,602,000 (-27.73%)

$151,666,000 (146.68%)

Accumulated Other Comprehensive Income

-$1,902,000 (49.25%)

-$3,748,000 (-328.34%)

-$875,000 (92.15%)

-$11,142,000 (-10.89%)

Deferred Revenue

$108,111,000 (-39.27%)

$178,033,000 (-3.46%)

$184,412,000 (-7.53%)

$199,422,000 (282.83%)

Total Investments

$60,466,000 (1951.78%)

$2,947,000 (-96.95%)

$96,572,000 (-56.03%)

$219,632,000 (-29.45%)

Investments Current

$60,466,000 (1951.78%)

$2,947,000 (-96.95%)

$96,572,000 (-56.03%)

$219,632,000 (-29.45%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$7,320,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,454,000 (77.10%)

$821,000 (-88.96%)

$7,435,000 (888.70%)

$752,000 (441.01%)

Trade & Non-Trade Payables

$8,692,000 (6.94%)

$8,128,000 (71.01%)

$4,753,000 (-41.42%)

$8,113,000 (26.98%)

Accumulated Retained Earnings (Deficit)

-$1,093,987,000 (-6.92%)

-$1,023,173,000 (-12.52%)

-$909,302,000 (-22.24%)

-$743,846,000 (-26.99%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$74,209,000 (194.07%)

$25,235,000 (9.35%)

$23,077,000 (-9.39%)

$25,468,000 (7.41%)

Debt Current

$4,709,000 (-12.54%)

$5,384,000 (97.36%)

$2,728,000 (17.59%)

$2,320,000 (-16.34%)

Debt Non-Current

$69,500,000 (250.11%)

$19,851,000 (-2.45%)

$20,349,000 (-12.09%)

$23,148,000 (10.55%)

Total Liabilities

$234,114,000 (-3.70%)

$243,103,000 (-1.59%)

$247,038,000 (-6.28%)

$263,585,000 (139.81%)

Liabilities Current

$64,527,000 (-11.35%)

$72,788,000 (12.85%)

$64,501,000 (3.13%)

$62,541,000 (60.06%)

Liabilities Non-Current

$169,587,000 (-0.43%)

$170,315,000 (-6.70%)

$182,537,000 (-9.21%)

$201,044,000 (183.79%)

ADAP Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$178,032,000 (195.34%)

$60,281,000 (122.05%)

$27,148,000 (341.50%)

$6,149,000 (55.36%)

Cost of Revenue

$70,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$87,261,000 (18.70%)

$73,513,000 (15.97%)

$63,387,000 (10.61%)

$57,305,000 (25.13%)

Research & Development Expense

$149,060,000 (17.83%)

$126,509,000 (-0.95%)

$127,726,000 (14.98%)

$111,090,000 (21.32%)

Operating Expenses

$246,722,000 (23.35%)

$200,022,000 (4.66%)

$191,113,000 (13.49%)

$168,395,000 (22.59%)

Interest Expense

$3,348,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$3,576,000 (167.66%)

$1,336,000 (-46.50%)

$2,497,000 (215.68%)

$791,000 (388.27%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$70,814,000 (37.81%)

-$113,871,000 (31.18%)

-$165,456,000 (-4.66%)

-$158,090,000 (-21.52%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$70,814,000 (37.81%)

-$113,871,000 (31.18%)

-$165,456,000 (-4.66%)

-$158,090,000 (-21.52%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$70,814,000 (37.81%)

-$113,871,000 (31.18%)

-$165,456,000 (-4.66%)

-$158,090,000 (-21.52%)

Weighted Average Shares

$1,513,810,852 (25.48%)

$1,206,440,978 (24.73%)

$967,242,403 (3.47%)

$934,833,017 (9.36%)

Weighted Average Shares Diluted

$1,513,810,852 (25.48%)

$1,206,440,978 (24.73%)

$967,242,403 (3.47%)

$934,833,017 (9.36%)

Earning Before Interest & Taxes (EBIT)

-$63,890,000 (43.23%)

-$112,535,000 (30.94%)

-$162,959,000 (-3.60%)

-$157,299,000 (-21.06%)

Gross Profit

$177,962,000 (195.22%)

$60,281,000 (122.05%)

$27,148,000 (341.50%)

$6,149,000 (55.36%)

Operating Income

-$68,760,000 (50.79%)

-$139,741,000 (14.77%)

-$163,965,000 (-1.06%)

-$162,246,000 (-21.62%)

ADAP Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$58,952,000 (-133.39%)

$176,538,000 (98.05%)

$89,137,000 (17.59%)

$75,800,000 (127.18%)

Net Cash Flow from Financing

$78,749,000 (8848.75%)

$880,000 (-93.16%)

$12,867,000 (291.33%)

$3,288,000 (-99.03%)

Net Cash Flow from Operations

-$73,206,000 (48.04%)

-$140,880,000 (0.63%)

-$141,769,000 (-1421.36%)

$10,729,000 (120.02%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$53,811,000 (-243.82%)

$37,415,000 (188.95%)

-$42,064,000 (-146.64%)

$90,182,000 (1271.38%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$45,264,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$56,361,000 (-141.74%)

$135,030,000 (13.59%)

$118,877,000 (40.55%)

$84,581,000 (130.64%)

Capital Expenditure

-$886,000 (81.07%)

-$4,681,000 (84.13%)

-$29,496,000 (-244.02%)

-$8,574,000 (-266.25%)

Issuance (Repayment) of Debt Securities

$49,500,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$29,249,000 (3223.75%)

$880,000 (-93.16%)

$12,867,000 (291.33%)

$3,288,000 (-99.03%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$402,000 (-145.84%)

$877,000 (138.15%)

-$2,299,000 (-729.86%)

$365,000 (138.02%)

Share Based Compensation

$12,051,000 (2.36%)

$11,773,000 (-35.46%)

$18,240,000 (-11.58%)

$20,629,000 (98.09%)

Depreciation Amortization & Accretion

$11,225,000 (14.08%)

$9,840,000 (61.98%)

$6,075,000 (-7.49%)

$6,567,000 (-13.52%)

ADAP Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-39.80% (78.93%)

-188.90% (69.01%)

-609.50% (76.29%)

-2571.00% (21.78%)

EBITDA Margin

-29.60% (82.63%)

-170.40% (70.51%)

-577.90% (76.42%)

-2451.30% (20.69%)

Return on Average Equity (ROAE)

-133.30% (1.04%)

-134.70% (-1.81%)

-132.30% (-116.18%)

-61.20% (-54.16%)

Return on Average Assets (ROAA)

-24.80% (34.04%)

-37.60% (16.44%)

-45.00% (-15.68%)

-38.90% (-29.24%)

Return on Sales (ROS)

-35.90% (80.77%)

-186.70% (68.90%)

-600.30% (76.53%)

-2558.10% (22.07%)

Return on Invested Capital (ROIC)

-50.50% (35.01%)

-77.70% (-8.52%)

-71.60% (-42.35%)

-50.30% (-26.70%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.8 (-22.26%)

-1.47 (-2.66%)

-1.43 (61.07%)

-3.68 (38.62%)

Price to Sales Ratio (P/S)

0.76 (-71.13%)

2.65 (-69.48%)

8.67 (-90.88%)

95.04 (-51.02%)

Price to Book Ratio (P/B)

11.64 (155.23%)

4.56 (56.02%)

2.92 (2.71%)

2.85 (16.36%)

Debt to Equity Ratio (D/E)

19.76 (221.16%)

6.15 (103.91%)

3.02 (135.70%)

1.28 (297.52%)

Earnings Per Share (EPS)

-0.3 (44.44%)

-0.54 (47.06%)

-1.02 (0.00%)

-1.02 (-13.33%)

Sales Per Share (SPS)

0.7 (135.00%)

0.3 (78.57%)

0.17 (330.77%)

0.04 (39.29%)

Free Cash Flow Per Share (FCFPS)

-0.29 (59.39%)

-0.72 (31.83%)

-1.06 (-7685.71%)

0.01 (103.56%)

Book Value Per Share (BVPS)

0.05 (-76.02%)

0.2 (-61.42%)

0.51 (-61.57%)

1.32 (-44.80%)

Tangible Assets Book Value Per Share (TABVPS)

0.96 (-31.70%)

1.4 (-31.08%)

2.04 (-32.26%)

3.01 (-4.66%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (0.00%)

-1 (75.00%)

-4 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.76 (-60.89%)

-1.1 (4.86%)

-1.15 (69.36%)

-3.76 (40.62%)

Asset Turnover

0.62 (213.07%)

0.2 (168.92%)

0.07 (393.33%)

0.01 (66.67%)

Current Ratio

2.92 (2.28%)

2.85 (-27.99%)

3.96 (-40.40%)

6.64 (-34.81%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$74,092,000 (49.10%)

-$145,561,000 (15.01%)

-$171,265,000 (-8047.33%)

$2,155,000 (103.85%)

Enterprise Value (EV)

$92,944,852 (-17.51%)

$112,672,448 (-37.72%)

$180,925,204 (-68.10%)

$567,218,378 (-26.83%)

Earnings Before Tax (EBT)

-$67,238,000 (40.25%)

-$112,535,000 (30.94%)

-$162,959,000 (-3.60%)

-$157,299,000 (-21.06%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$52,665,000 (48.72%)

-$102,695,000 (34.54%)

-$156,884,000 (-4.08%)

-$150,732,000 (-23.21%)

Invested Capital

$158,559,000 (80.76%)

$87,716,000 (-50.57%)

$177,448,000 (-36.58%)

$279,806,000 (-24.90%)

Working Capital

$123,642,000 (-8.25%)

$134,764,000 (-29.39%)

$190,869,000 (-45.92%)

$352,917,000 (-1.72%)

Tangible Asset Value

$242,083,000 (-14.24%)

$282,286,000 (-14.06%)

$328,474,000 (-29.89%)

$468,545,000 (4.26%)

Market Capitalization

$137,871,852 (-23.47%)

$180,143,448 (-24.70%)

$239,238,204 (-59.17%)

$585,882,378 (-29.79%)

Average Equity

$53,121,750 (-37.17%)

$84,542,250 (-32.40%)

$125,069,250 (-51.62%)

$258,509,750 (-21.13%)

Average Assets

$285,777,750 (-5.55%)

$302,579,750 (-17.62%)

$367,296,750 (-9.56%)

$406,111,750 (-5.97%)

Invested Capital Average

$126,468,000 (-12.67%)

$144,821,750 (-36.41%)

$227,735,750 (-27.20%)

$312,814,500 (-4.51%)

Shares

1,535,299,242 (12.66%)

1,362,729,582 (38.63%)

982,974,108 (4.88%)

937,224,360 (0.92%)

Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.